Fox RI. (2005) Sjögren’s syndrome. Lancet. 366(9482):321 − 31. https://doi.org/10.1016/S0140-6736(05)66990-5

Mariette, X., & Criswell, L. A. (2018). Primary Sjögren’s Syndrome. The New England journal of medicine, 378(10):931–939. https://doi.org/10.1056/NEJMcp1702514

Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T (2017). The Diagnosis and Treatment of Sjögren’s Syndrome. Dtsch Arztebl Int. 114(20):354–361. https://doi.org/10.3238/arztebl.2017.0354

Seror R, Ravaud P, Bowman SJ, Baron G, Tzioufas A, Theander E, Gottenberg JE, Bootsma H, Mariette X, Vitali C (2010); EULAR Sjögren’s Task Force. EULAR Sjogren’s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren’s syndrome. Ann Rheum Dis. 69(6):1103-9. https://doi.org/10.1136/ard.2009.110619

Ramos-Casals M, Brito-Zerón P, Solans R, Camps MT, Casanovas A, Sopeña B, Díaz-López B, Rascón FJ, Qanneta R, Fraile G, Pérez-Alvarez R, Callejas JL, Ripoll M, Pinilla B, Akasbi M, Fonseca E, Canora J, Nadal ME, de la Red G, Fernández-Regal I, Jiménez-Heredia I, Bosch JA, Ayala MD, Morera-Morales L, Maure B, Mera A, Ramentol M, Retamozo S, Kostov B; SS Study Group (2014); Autoimmune Diseases Study Group (GEAS) of the Spanish Society of Internal Medicine (SEMI). Systemic involvement in primary Sjogren’s syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry). Rheumatology (Oxford). 53(2):321 − 31. https://doi.org/10.1093/rheumatology/ket349

Ye W, Chen S, Huang X, Qin W, Zhang T, Zhu X, Zhu X, Lin C, Wang X (2018). Clinical features and risk factors of neurological involvement in Sjögren’s syndrome. BMC Neurosci. 19(1):26. https://doi.org/10.1186/s12868-018-0427-y

Módis LV, Aradi Z, Horváth IF, Bencze J, Papp T, Emri M, Berényi E, Bugán A, Szántó A (2022). Central Nervous System Involvement in Primary Sjögren’s Syndrome: Narrative Review of MRI Findings. Diagnostics (Basel). 13(1):14. https://doi.org/10.3390/diagnostics13010014

Perzyńska-Mazan J, Maślińska M, Gasik R (2018). Neurological manifestations of primary Sjögren’s syndrome. Reumatologia. 56(2):99–105. https://doi.org/10.5114/reum.2018.75521

Fauchais AL, Magy L, Vidal E (2012). Central and peripheral neurological complications of primary Sjögren’s syndrome. Presse Med. 41(9 Pt 2):e485-93. https://doi.org/10.1016/j.lpm.2012.06.002

Barsottini OGP, Moraes MPM, Fraiman PHA, Marussi VHR, Souza AWS, Braga Neto P, Spitz M (2023). Sjogren’s syndrome: a neurological perspective. Arq Neuropsiquiatr. 81(12):1077–1083. https://doi.org/10.1055/s-0043-1777105

Carvajal Alegria G, Guellec D, Mariette X, Gottenberg JE, Dernis E, Dubost JJ, Trouvin AP, Hachulla E, Larroche C, Le Guern V, Cornec D, Devauchelle-Pensec V, Saraux A (2016). Epidemiology of neurological manifestations in Sjögren’s syndrome: data from the French ASSESS Cohort. RMD Open. 2(1):e000179. https://doi.org/10.1136/rmdopen-2015-000179

Morreale M, Marchione P, Giacomini P, Pontecorvo S, Marianetti M, Vento C, Tinelli E, Francia A (2014). Neurological involvement in primary Sjögren syndrome: a focus on central nervous system. PLoS One. 9(1):e84605. https://doi.org/10.1371/journal.pone.0084605

Hassin-Baer S, Levy Y, Langevitz P, Nakar S, Ehrenfeld M (2007). Anti-beta2-glycoprotein I in Sjogren’s syndrome is associated with parkinsonism. Clin Rheumatol. 26(5):743-7. https://doi.org/10.1007/s10067-006-0398-8

Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004). Neurologic manifestations in primary Sjögren syndrome: a study of 82 patients. Medicine (Baltimore). 83(5):280–291 https://doi.org/10.1097/01.md.0000141099.53742.16

Khalayli N, Kudsi M (2022). Sjögren’s syndrome with bipolar disorder, case report. Ann Med Surg (Lond). 80:104243. https://doi.org/10.1016/j.amsu.2022.104243

Pelizza L, Bonacini F, Ferrari A (2010). Psychiatric disorder as clinical presentation of primary Sjögren’s syndrome: two case reports. Ann Gen Psychiatry. 9:12. https://doi.org/10.1186/1744-859X-9-12

Smiyan S, Komorovsky R, Koshak B, Duve K, Shkrobot S (2024). Central nervous system manifestations in rheumatic diseases. Rheumatol Int. 44(10):1803–1812. https://doi.org/10.1007/s00296-024-05679-1

Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X (2017); International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol. 69(1):35–45. https://doi.org/10.1002/art.39859

Both T, Dalm VA, van Hagen PM, van Daele PL (2017). Reviewing primary Sjögren’s syndrome: beyond the dryness - From pathophysiology to diagnosis and treatment. Int J Med Sci. 14(3):191–200. https://doi.org/10.7150/ijms.17718

Patel R, Shahane A (2014). The epidemiology of Sjögren’s syndrome. Clin Epidemiol. 6:247 − 55. https://doi.org/10.2147/CLEP.S47399

Carteron NL, Bootsma H, Kroese FGM, Vissink A, Dumusc A, Bowman SJ. Clinical Aspects of Sjögren’s. In Wallace DJ, Hahn BH, editors, Dubois’ Lupus Erythematosus and Related Syndromes. 9th ed. Elsevier. 2018. p. 566–578. https://doi.org/10.1016/B978-0-323-47927-1.00045-1

Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C (2020). Current State of Knowledge on Primary Sjögren’s Syndrome, an Autoimmune Exocrinopathy. J Clin Med. 9(7):2299. https://doi.org/10.3390/jcm9072299

Barroso B (2007). Primary Sjögren’s syndrome mimicking neuromyelitis optica. Eur J Intern Med. 18(6):507. https://doi.org/10.1016/j.ejim.2007.02.009

Fujimoto K, Norikane T, Yamamoto Y, Takami Y, Murota M, Shimada H, Dobashi H, Nishiyama Y (2022). Cardiac Sarcoidosis Mimicking Lymphoma in a Patient With Sjogren’s Syndrome. Korean Circ J. 52(9):715–716. https://doi.org/10.4070/kcj.2022.0068

Kamogawa Y, Akita K, Sato H, Shirai T, Ishii T, Harigae H, Fujii H (2022). Sjögren’s Syndrome Presenting with Temporary Hemiplegia Mimicking Transient Ischemic Attack. Tohoku J Exp Med. 258(3):207–211. https://doi.org/10.1620/tjem.2022.J079

McCrary HC, Faucett EA, Erman AB (2016). Immunoglobulin G4-related sclerosing disease Mimicking sjogren’s syndrome: A case report. Laryngoscope. 126(10):2242-5. https://doi.org/10.1002/lary.26112

Matsuo K, Saburi M, Ishikawa H, Tei K, Hosokawa Y, Fujii C, Mizuno T, Nakagawa M (2013). Sjögren syndrome presenting with encephalopathy mimicking Creutzfeldt-Jakob disease. J Neurol Sci. 326(1–2):100-3. https://doi.org/10.1016/j.jns.2013.01.005

Tuisku IS, Konttinen YT, Soinila S, Karma A, Tervo TM (2004). Neurosarcoidosis mimicking Sjögren’s syndrome. Acta Ophthalmol Scand. 82(5):599–602. https://doi.org/10.1111/j.1600-0420.2004.00369.x

Konak HE, Gök K, Armağan B, Güven SC, Atalar E, Apaydın H, Maraş Y, Erten Ş (2023). Neurological Involvement in Patients with Primary Sjögren’s Syndrome: A Retrospective Cross-Sectional Study. Ann Indian Acad Neurol. 26(4):424–430. https://doi.org/10.4103/aian.aian_138_23

Fan G, Dai F, Chen S, Sun Y, Qian H, Yang G, Liu Y, Shi G (2021). Neurological Involvement in Patients With Primary Sjögren’s Syndrome. J Clin Rheumatol. 27(2):50–55. https://doi.org/10.1097/RHU.0000000000001128

Dułak NA, Rytlewska M, Jaskólska M, Chmielewski M (2024). A new perspective on vitamin B12 deficiency in rheumatology: a case-based review. Rheumatol Int. 44(4):737–741. https://doi.org/10.1007/s00296-024-05539-y

Seeliger T, Kramer E, Konen FF, Zehrfeld N, Beider S, Prenzler NK, Gödecke V, Witte T, Skripuletz T, Ernst D (2023). Sjögren’s syndrome with and without neurological involvement. J Neurol. 270(6):2987–2996. https://doi.org/10.1007/s00415-023-11613-5

Afzali AM, Moog P, Kalluri SR, Hofauer B, Knopf A, Kirschke JS, Hemmer B, Berthele A (2023). CNS demyelinating events in primary Sjögren’s syndrome: A single-center case series on the clinical phenotype. Front Neurol. 14:1128315. https://doi.org/10.3389/fneur.2023.1128315

Massara A, Bonazza S, Castellino G, Caniatti L, Trotta F, Borrelli M, Feggi L, Govoni M (2010). Central nervous system involvement in Sjögren’s syndrome: unusual, but not unremarkable–clinical, serological characteristics and outcomes in a large cohort of Italian patients. Rheumatology (Oxford). 49(8):1540-9. https://doi.org/10.1093/rheumatology/keq111

Moreira I, Teixeira F, Martins Silva A, Vasconcelos C, Farinha F, Santos E (2015). Frequent involvement of central nervous system in primary Sjögren syndrome. Rheumatol Int. 35(2):289 − 94. https://doi.org/10.1007/s00296-014-3097-9

Wang ZZ, Liu MS, Sun Z, Zhang XL, Zhang ML, Xiong K, Zhou F (2022). Risk of dementia or Parkinson’s disease in the presence of Sjögren’s syndrome: A systematic review and meta-analysis. Front Integr Neurosci. 16:1027044. https://doi.org/10.3389/fnint.2022.1027044

Hsu HC, Hou TY, Lin TM, Chang YS, Chen WS, Kuo PI, Lin YC, Chang CC, Chen JH (2020). Higher risk of Parkinson disease in patients with primary Sjögren’s syndrome. Clin Rheumatol. 39(10):2999–3007. https://doi.org/10.1007/s10067-020-05053-z

Kchaou M, Ben Ali N, Hmida I, Fray S, Jamoussi H, Jalleli M, Echebbi S, Achouri A, Belal S (2015). Parkinsonism and Sjögren’s Syndrome: A Fortuitous Association or a Shared Immunopathogenesis? Case Rep Med. 2015:432910. https://doi.org/10.1155/2015/432910

Créange A, Sedel F, Brugières P, Voisin MC, Degos JD (1997). Primary Sjögren’s syndrome presenting as progressive parkinsonian syndrome. Mov Disord. 12(1):121-3. https://doi.org/10.1002/mds.870120124

Nishimura H, Tachibana H, Makiura N, Okuda B, Sugita M (1994). Corticosteroid-responsive parkinsonism associated with primary Sjögren’s syndrome. Clin Neurol Neurosurg. 96(4):327 − 31. https://doi.org/10.1016/0303-8467(94)90124-4

Tzarouchi LC, Tsifetaki N, Konitsiotis S, Zikou A, Astrakas L, Drosos A, Argyropoulou MI (2011). CNS involvement in primary Sjogren Syndrome: assessment of gray and white matter changes with MRI and voxel-based morphometry. AJR Am J Roentgenol. 197(5):1207-12. https://doi.org/10.2214/AJR.10.5984

Alhomoud IA, Bohlega SA, Alkawi MZ, Alsemari AM, Omer SM, Alsenani FM (2009). Primary Sjogren’s syndrome with central nervous system involvement. Saudi Med J. 30(8):1067-72. PMID: 19668890.

Fan W, Par-Young J, Li K, Zhang Y, Xiao P, Hua L, Leng L, Chen X, Bucala R (2023). Clinical features and high-risk indicators of central nervous system involvement in primary Sjögren’s syndrome. Clin Rheumatol. 42(2):443–451. https://doi.org/10.1007/s10067-022-06448-w

Morgen K, McFarland HF, Pillemer SR (2004). Central nervous system disease in primary Sjogrens syndrome: the role of magnetic resonance imaging. Semin Arthritis Rheum. 34(3):623 − 30. https://doi.org/10.1016/j.semarthrit.2004.07.005

Harboe E, Beyer MK, Greve OJ, Gøransson LG, Tjensvoll AB, Kvaløy JT, Omdal R (2009). Cerebral white matter hyperintensities are not increased in patients with primary Sjögren’s syndrome. Eur J Neurol. 16(5):576 − 81. https://doi.org/10.1111/j.1468-1331.2009.02537.x

Pars K, Pul R, Schwenkenbecher P, Sühs KW, Wurster U, Witte T, Bronzlik P, Stangel M, Skripuletz T (2017). Cerebrospinal Fluid Findings in Neurological Diseases Associated with Sjögren’s Syndrome. Eur Neurol. 77(1–2):91–102. https://doi.org/10.1159/000454765

Tjensvoll AB, Lauvsnes MB, Zetterberg H, Kvaløy JT, Kvivik I, Maroni SS, Greve OJ, Beyer MK, Hirohata S, Putterman C, Alves G, Harboe E, Blennow K, Gøransson LG, Omdal R (2021). Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren’s syndrome. J Neurol. 268(4):1385–1394. https://doi.org/10.1007/s00415-020-10290-y

Castellazzi M, Candeloro R, Pugliatti M, Govoni M, Silvagni E, Bortoluzzi A (2024). Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review. Diagnostics (Basel). 14(3):242. https://doi.org/10.3390/diagnostics14030242

Alexander EL, Provost TT, Sanders ME, Frank MM, Joiner KA (1988). Serum complement activation in central nervous system disease in Sjögren’s syndrome. Am J Med. 85(4):513-8. https://doi.org/10.1016/s0002-9343(88)80087-1

Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H (2011). Clinical manifestations of neurological involvement in primary Sjögren’s syndrome. Clin Rheumatol. 30(4):485 − 90. https://doi.org/10.1007/s10067-010-1458-7

Tetsuka S, Suzuki T, Ogawa T, Hashimoto R, Kato H (2021). Anti-Ro/SSA Antibodies May Be Responsible for Cerebellar Degeneration in Sjogren’s Syndrome. J Clin Med Res. 13(2):113–120. https://doi.org/10.14740/jocmr4429

Sève P, Gachon E, Petiot P, Stankovic K, Charhon A, Broussolle C (2007). Successful treatment with rituximab in a patient with mental nerve neuropathy in primary Sjögren’s syndrome. Rheumatol Int. 28(2):175-7. https://doi.org/10.1007/s00296-007-0396-4

Govoni M, Padovan M, Rizzo N, Trotta F (2001). CNS involvement in primary Sjögren’s syndrome: prevalence, clinical aspects, diagnostic assessment and therapeutic approach. CNS Drugs. 15(8):597–607. https://doi.org/10.2165/00023210-200115080-00003

Soliotis FC, Mavragani CP, Moutsopoulos HM (2004). Central nervous system involvement in Sjogren’s syndrome. Ann Rheum Dis. 63(6):616 − 20. https://doi.org/10.1136/ard.2003.019497

Mehta P, Zimba O, Gasparyan AY, Seiil B, Yessirkepov M (2023). Ethics Committees: Structure, Roles, and Issues. J Korean Med Sci. 38(25):e198. https://doi.org/10.3346/jkms.2023.38.e198